K J Somaiya contest promotes nursing-led healthcare innovation
The competition received over 42 entries from nursing colleges across Maharashtra
The competition received over 42 entries from nursing colleges across Maharashtra
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
Subscribe To Our Newsletter & Stay Updated